PFM Health Sciences as of March 31, 2022
Portfolio Holdings for PFM Health Sciences
PFM Health Sciences holds 68 positions in its portfolio as reported in the March 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Outset Med (OM) | 4.8 | $128M | 2.8M | 45.40 | |
Horizon Therapeutics Pub L SHS | 4.3 | $115M | 1.1M | 105.21 | |
Arcus Biosciences Incorporated (RCUS) | 4.0 | $108M | 3.4M | 31.56 | |
Johnson & Johnson (JNJ) | 3.9 | $104M | 585k | 177.23 | |
Centene Corporation (CNC) | 3.5 | $94M | 1.1M | 84.19 | |
Cytokinetics Com New (CYTK) | 3.4 | $91M | 2.5M | 36.81 | |
Eli Lilly & Co. (LLY) | 3.2 | $86M | 299k | 286.37 | |
Gilead Sciences Call Call Option | 3.1 | $84M | 1.4M | 59.45 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 3.0 | $80M | 516k | 155.67 | |
Irhythm Technologies (IRTC) | 2.9 | $78M | 494k | 157.47 | |
Humana (HUM) | 2.7 | $72M | 166k | 435.17 | |
Avantor (AVTR) | 2.6 | $70M | 2.1M | 33.82 | |
Pfizer (PFE) | 2.6 | $70M | 1.3M | 51.77 | |
Universal Hlth Svcs CL B (UHS) | 2.4 | $64M | 441k | 144.95 | |
UnitedHealth (UNH) | 2.1 | $57M | 112k | 509.97 | |
BioMarin Pharmaceutical (BMRN) | 2.1 | $55M | 719k | 77.10 | |
Danaher Corporation (DHR) | 1.9 | $52M | 176k | 293.33 | |
Iqvia Holdings (IQV) | 1.9 | $51M | 222k | 231.21 | |
ICU Medical, Incorporated (ICUI) | 1.8 | $49M | 221k | 222.64 | |
Molina Healthcare (MOH) | 1.8 | $48M | 144k | 333.59 | |
Myriad Genetics (MYGN) | 1.8 | $47M | 1.9M | 25.20 | |
Nevro (NVRO) | 1.8 | $47M | 650k | 72.33 | |
Tenet Healthcare Corp Com New (THC) | 1.8 | $47M | 545k | 85.96 | |
Biomarin Pharmaceutical Note 0.599% 8/0 (Principal) | 1.7 | $46M | 46M | 1.00 | |
Aerie Pharmaceuticals Note 1.500%10/0 (Principal) | 1.6 | $44M | 48M | 0.91 | |
Becton, Dickinson and (BDX) | 1.6 | $42M | 158k | 266.00 | |
Dynavax Technologies Corp Com New (DVAX) | 1.5 | $41M | 3.8M | 10.84 | |
Erasca (ERAS) | 1.5 | $41M | 4.8M | 8.60 | |
Caribou Biosciences (CRBU) | 1.5 | $40M | 4.4M | 9.18 | |
Edwards Lifesciences (EW) | 1.5 | $40M | 338k | 117.72 | |
Icon SHS (ICLR) | 1.4 | $39M | 158k | 243.22 | |
Penumbra (PEN) | 1.4 | $37M | 167k | 222.13 | |
Thermo Fisher Scientific (TMO) | 1.4 | $37M | 62k | 590.65 | |
Waters Corporation (WAT) | 1.4 | $37M | 118k | 310.39 | |
Cardinal Health (CAH) | 1.4 | $36M | 640k | 56.70 | |
Syndax Pharmaceuticals (SNDX) | 1.3 | $36M | 2.0M | 17.38 | |
Sierra Oncology Com New | 1.3 | $34M | 1.1M | 32.05 | |
McKesson Corporation (MCK) | 1.2 | $32M | 106k | 306.13 | |
Astrazeneca Sponsored Adr (AZN) | 1.1 | $30M | 452k | 66.34 | |
Catalent | 1.1 | $28M | 256k | 110.90 | |
Jounce Therapeutics | 1.0 | $27M | 4.0M | 6.79 | |
Karuna Therapeutics Ord | 1.0 | $26M | 207k | 126.79 | |
Cigna Corp (CI) | 0.8 | $23M | 94k | 239.61 | |
Anthem (ELV) | 0.8 | $21M | 43k | 491.22 | |
Intellia Therapeutics (NTLA) | 0.8 | $21M | 288k | 72.67 | |
Heron Therapeutics (HRTX) | 0.8 | $20M | 3.5M | 5.72 | |
Hca Holdings (HCA) | 0.8 | $20M | 80k | 250.62 | |
Dex (DXCM) | 0.7 | $19M | 37k | 511.60 | |
Iveric Bio | 0.6 | $17M | 1.0M | 16.83 | |
Sophia Genetics Sa Ordinary Shares (SOPH) | 0.6 | $16M | 2.0M | 7.73 | |
Gilead Sciences (GILD) | 0.6 | $15M | 250k | 59.45 | |
Oak Street Health | 0.5 | $14M | 524k | 26.88 | |
Aerie Pharmaceuticals | 0.4 | $9.9M | 1.1M | 9.10 | |
Uniqure Nv SHS (QURE) | 0.4 | $9.7M | 535k | 18.07 | |
Pmv Pharmaceuticals (PMVP) | 0.3 | $9.3M | 446k | 20.82 | |
Praxis Precision Medicines I | 0.3 | $8.8M | 865k | 10.21 | |
Verve Therapeutics (VERV) | 0.3 | $8.4M | 370k | 22.82 | |
Cano Health Com Cl A | 0.3 | $8.3M | 1.3M | 6.35 | |
C4 Therapeutics Com Stk (CCCC) | 0.3 | $6.9M | 285k | 24.26 | |
Io Biotech (IOBT) | 0.2 | $6.6M | 1.4M | 4.88 | |
Pardes Biosciences | 0.2 | $5.3M | 730k | 7.22 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.2 | $4.9M | 2.4M | 2.06 | |
Bcls Acquisition Corp Com Cl A | 0.2 | $4.6M | 464k | 9.87 | |
Jiya Acquisition Corp Com Cl A | 0.2 | $4.6M | 464k | 9.83 | |
Generation Bio (GBIO) | 0.2 | $4.2M | 574k | 7.34 | |
D Fluidigm Corp Del (LAB) | 0.1 | $3.5M | 981k | 3.59 | |
Sana Biotechnology (SANA) | 0.1 | $2.9M | 355k | 8.26 | |
Werewolf Therapeutics (HOWL) | 0.1 | $2.6M | 585k | 4.40 |